APGE · Apogee Therapeutics, Inc.
$134.75
+0.04 (+0.03%)
At close · Aug 20
Going-concern doubt
— cleared Aug 10, 2026
The latest filing states the doubt was alleviated.
“The Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date that the accompanying consolidated financial statements are issued. ... Based on the Company's current operating plan, it estimates that its existing cash and cash equivalents of $105.6 million, marketable securities of $866.4 million and long-term marketable securities of $321.9 million as of June 30, 2026, will be sufficient to enable the Company to fund its operating expenses and capital requirements through at least the next 12 months from the issuance of these consolidated financial statements.”View the 10-Q filed Aug 10, 2026
Market Cap
$10.20B
Shares
75.69M
Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.
Short Volume
| Date | Short Volume | Short Exempt | Total Volume | Short % |
|---|---|---|---|---|
| 2026-08-20 | 102,156 | 155 | 603,116 | 16.9% |
| 2026-08-19 | 57,509 | 0 | 607,304 | 9.5% |
| 2026-08-18 | 82,467 | 0 | 373,366 | 22.1% |
| 2026-08-17 | 104,817 | 8,140 | 389,940 | 26.9% |
| 2026-08-14 | 406,062 | 1,524 | 771,840 | 52.6% |
| 2026-08-13 | 95,331 | 2,011 | 323,290 | 29.5% |
| 2026-08-12 | 62,836 | 2 | 282,290 | 22.3% |
| 2026-08-11 | 205,184 | 1 | 557,958 | 36.8% |
| 2026-08-10 | 56,557 | 17 | 211,942 | 26.7% |
| 2026-08-07 | 94,810 | 1,019 | 675,693 | 14.0% |
| 2026-08-06 | 75,541 | 2 | 408,015 | 18.5% |
| 2026-08-05 | 82,491 | 6,914 | 1,001,635 | 8.2% |
| 2026-08-04 | 466,015 | 2,000 | 1,544,444 | 30.2% |
| 2026-08-03 | 93,135 | 0 | 300,039 | 31.0% |
| 2026-07-31 | 107,687 | 18 | 812,091 | 13.3% |
| 2026-07-30 | 63,705 | 0 | 257,615 | 24.7% |
| 2026-07-29 | 95,549 | 385 | 324,413 | 29.5% |
| 2026-07-28 | 85,458 | 429 | 305,289 | 28.0% |
| 2026-07-27 | 78,790 | 5,010 | 159,813 | 49.3% |
| 2026-07-24 | 49,391 | 0 | 81,853 | 60.3% |
| 2026-07-23 | 76,765 | 1,117 | 173,943 | 44.1% |
| 2026-07-22 | 140,500 | 2 | 403,700 | 34.8% |
| 2026-07-21 | 74,859 | 200 | 113,772 | 65.8% |
| 2026-07-20 | 106,236 | 0 | 262,398 | 40.5% |
| 2026-07-17 | 91,278 | 652 | 953,483 | 9.6% |
| 2026-07-16 | 153,180 | 301 | 411,290 | 37.2% |
| 2026-07-15 | 59,757 | 0 | 163,596 | 36.5% |
| 2026-07-14 | 116,364 | 91 | 406,190 | 28.6% |
| 2026-07-13 | 57,584 | 0 | 148,090 | 38.9% |
| 2026-07-10 | 78,604 | 0 | 229,065 | 34.3% |
| 2026-07-09 | 147,871 | 0 | 599,180 | 24.7% |
| 2026-07-08 | 217,364 | 0 | 604,718 | 35.9% |
| 2026-07-07 | 129,713 | 101 | 453,900 | 28.6% |
| 2026-07-06 | 131,243 | 0 | 730,526 | 18.0% |
| 2026-07-02 | 136,498 | 15,863 | 1,112,942 | 12.3% |
| 2026-07-01 | 555,942 | 1,596 | 1,668,025 | 33.3% |
| 2026-06-30 | 170,953 | 6 | 2,704,537 | 6.3% |
| 2026-06-29 | 72,686 | 3,540 | 1,028,140 | 7.1% |
| 2026-06-26 | 388,248 | 1,843 | 2,285,555 | 17.0% |
| 2026-06-25 | 590,644 | 466 | 2,317,012 | 25.5% |
| 2026-06-24 | 827,861 | 39 | 3,837,237 | 21.6% |
| 2026-06-23 | 862,608 | 1,481 | 5,940,110 | 14.5% |
| 2026-06-22 | 3,187,263 | 20,894 | 23,377,939 | 13.6% |
| 2026-06-18 | 246,140 | 1,497 | 353,497 | 69.6% |
| 2026-06-17 | 231,299 | 0 | 376,052 | 61.5% |
| 2026-06-16 | 177,379 | 0 | 332,345 | 53.4% |
| 2026-06-15 | 132,636 | 1,385 | 243,467 | 54.5% |
| 2026-06-12 | 221,586 | 201 | 245,886 | 90.1% |
| 2026-06-11 | 249,688 | 5,692 | 295,762 | 84.4% |
| 2026-06-10 | 229,296 | 100 | 354,333 | 64.7% |
Showing 1–50 of 63 days
Key facts
CIK
1974640
CUSIP
03770N101
13F (30d)
277 filings
275 filers
Visit website
Investor relations